Italfarmaco is marching toward regulators after muscular dystrophy drug meets key goal

The latest stories trending on MedCity News.

Not rendering correctly? View this email as a web page here. TOP STORIES As muscular dystrophy drug meets key goal, Italfarmaco plans march forward to regulators A Duchenne muscular dystrophy drug candidate from Italfarmaco Group has encouraging preliminary data from a pivotal study. The Milan, Italy-based pharmaceutical company says it now plans to meet with U.S. and European authorities about seeking regulatory approval for the small molecule. Sponsored Content How health tech can improve the patient and provider experience From Microsoft and MedCity News The healthcare industry has wrestled with the impacts of the Covid-19 pandemic for more than two years. Much has been asked of clinicians, who have faced unprecedented stress from the workload these cases have presented. They've had to nimbly adapt to the rapid scaling of telehealth and transform the way they work. Hospitals have grappled with provider burnout, staff shortages, and more. In a series of interviews during the Microsoft Envision Healthcare Summit, attention is drawn to the myriad of ways cloud computing technology touches different aspects of healthcare across providers, payers, medtech, and pharmaceuticals. Leaders in healthcare highlight ways to improve care delivery, outcomes, a sustainable clinician workforce, and improving the patient experience. 1 Day of High-Quality, In-Person Meetings Around Digital Health Technology From MedCity News Join us in Dallas for MedCity INVEST Digital Health on Wednesday, September 28.  Don't miss out on this valuable opportunity to meet and discuss the latest trends and opportunities. Don't miss your chance to save with the Super Early Bird Rate. Report: Doctors want health systems to be more involved in maintaining their digital provider profiles By Katie Adams Monday, June 27, 2022 7:00 AM Providers' digital profiles must be robust in order to best attract and retain patients, according to a new report. Nearly all providers included in the study said that it is important for the hospitals or health systems that employ them to take a more active role in managing their profiles. Read more » A myopic approach to merger regulation fails consumers instead of protecting them By Michael Abrams Monday, June 27, 2022 1:30 AM Consolidated healthcare systems – even cross market systems – don't have to raise their prices to have anticompetitive effects. They can leverage their size by using the volume of their purchases to extract discounts and other concessions from payers, national suppliers, and from labor pools. Read more » Thought partnerships: The new frontier of client-agency partnerships By Andy Parratt and Krista Perry Monday, June 27, 2022 12:54 AM With emerging biotech needing help with a little bit of everything, these preferred partnerships can deliver a type of one-stop shopping leveraging an agency's best practices, current trends, and data. Read more » How small biotech companies can make the most out of today's deal-making landscape By Denise Mueller Monday, June 27, 2022 12:40 AM For small biotech companies that are always raising money, business development is a critical next step. Joining with a credible partner goes a long way in validating technology and platforms and gives small biotech companies the runway needed to grow. Read more » Re-Defining Healthcare Recruitment with Deep Learning Automation Replace the tedious manual resume screening process! Learn how AI frameworks and technology are streamlining the recruiter/candidate experience, resulting in healthcare industries hiring skilled and knowledgeable personnel quickly and effectively. Download this FREE eBook to learn more! MedCity News   611 Broadway    New York,  NY   10012   United States You received this email because you are subscribed to MedCity Daily Digest from MedCity News. Update your email preferences to choose the types of emails you receive.  Unsubscribe from all future emails